In a year from now, progress is to be measured in the institutionalisation of the approach with greater regulatory acceptance…
Infosys co-founder Kris Gopalakrishnan highlights key Budget announcements, including data centre incentives, services-led growth, clean-up measures and support for women…
Bharat Biotech chairman Dr Krishna Ella says employment generation is the central theme of Budget schemes, with major opportunities in…
In the goal to ensure 10 per cent of global services come from India, healthcare could be a huge contributor…
World Health Organisation’s former and first chief scientist Dr Soumya Swaminathan sees the in-house strengthening of CDSCO’s scientific skills and…
The Economic Survey’s FDI roadmap stresses stability and outreach, but economists say faster approvals and simpler processes are crucial to…
It is perhaps time for a national debate and consensus-building on enforcing a fiscal responsibility on transfer payments leading to…
Budget: Expect ‘Jan Vishwas 3.0’, mega multi-year schemes & hope privatisation-backed fiscal probity
Ahead of the Union Budget, industry expects Jan Vishwas 3.0, deregulation, mega multi-year schemes and a renewed push for privatisation…
Budget 2026 expectations: India Inc. on global competitiveness, R&D, AI and growth roadmap
To be counted among the developed nations, India will need to grow at over 7 per cent each year consistently…
The year 2025 has been a significant one for the Indian pharmaceutical sector. It witnessed several novel launches, collaborations, digital…
The RBI bulletin’s summary of the developments during the year does point to a year well-concluded despite challenges. It also…
With low-cost land banks becoming a scare commodity for pharma and other sectors that need energy intensive operations, effluent treatment…
Vikrant Shrotriya, Novo Nordisk India MD responds to questions on future pricing, generics competition post patent expiry in March, Indian-specific…
The class of GLP-1 agonist medications act by lowering the appetite with applications way beyond diabetes. These medicines will be…
In an impassionate address at ‘Telangana Rising Global Summit’ in Hyderabad, Eric Swider, director Trump Media & Technology Group, described…
Extreme weather events, says an RBI report, could reduce India’s GDP by 2 per cent to 6 per cent annually…
Biocon Limited (which holds around 78 per cent) will acquire the remaining stake in Biocon Biologics through a share swap…
